
Mara Gilardi
@gilardimara
SME in immuno-oncology at Champions Oncology
Cancer immunology; immunotherapy, microfluidics, personalized medicine.
ID: 1365687537197588483
https://scholar.google.com/citations?user=dLBgNikAAAAJ&hl=en 27-02-2021 15:38:34
22 Tweet
70 Followers
132 Following


So happy to share our recent study on multimodal precision immunotherapy! An amazing multidisciplinary team, bringing together precision medicine to immune oncology (Pharmacology2.0) IOTN Moonshot Umamaheswar Duvvuri MD PhD Joseph Califano UCSD Cancer Ezra Cohen Robert S-K

Led by GutkindLab, UCSD Health Moores Cancer Center CRCERA scientists employed an unbiased kinome-wide siRNA screen to reveal that HER3, was essential for the proliferation of most head and neck squamous cell carcinoma cells that did not harbor PIK3CA mutations. Nature Communications: go.nature.com/32RWIpg




Daniel Hollern Mara Gilardi Welcome to Salk!



Our team is coming together. Welcome to the Salk Institute and the Hollern Lab James Terzian and Kendrick Nguyen!



We (Brad Nelson, Dan Hollern, Tullia Bruno, and Marie-Caroline Dieu-Nosjean) have developed a virtual seminar series through our new B cells in Cancer Consortium (BC^3) group. Check out the info and participate! #Bcells #Bcellsincancer Daniel Hollern


Check out the fall speaker line up for our new virtual seminar series on B cells and TLS! Spread the word! #BC3 #Bcells Jennifer Wargo MD Mark Shlomchik Lab Maxime Meylan Dr.YayaTheScientist Nik Joshi Andreas Wieland


So proud to be part of this! Cancer will not win!@hollern_daniel Salk Institute Cancer Center






Can't wait, going to be a great event. Mara Gilardi will be representing our lab with a poster on her metastasis work.
